Trial intelligence / Profile preview

Comparison of liraglutide and radiofrequency cavitation for abdominal obesity

IRCT20150706023084N30Phase 3Completed

Sponsor
Islamic Azad University
Start
Nov 2025
Modality
Peptides
Countries
1
01

Overview

Phase 3 trial of liraglutide in obesity (2 arms), sponsored by Islamic Azad University. Started Nov 2025; status: completed.

02

Drugs

03

Conditions

obesity

Beyond the preview

Go deeper on IRCT20150706023084N30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20150706023084N30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call